# OnCo record idea-upgrade-rituximab-igm-flare-prevention-comparison (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-upgrade-rituximab-igm-flare-prevention-comparison/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-upgrade-rituximab-igm-flare-prevention-comparison" ;
  schema:name "Plasma exchange before rituximab compared with holding rituximab back, for a high IgM in Waldenström macroglobulinaemia"@en ;
  schema:description "Rituximab can push the abnormal IgM protein up for a few weeks before bringing it down, which can thicken the blood when the level is already high. Hospitals prevent this differently: plasma exchange first, leaving rituximab out of the first cycles, or watching closely. No study has compared them, and the two guidelines that recommend acting grade their evidence as low."@en ;
  schema:url <https://onco.cc/ideas/idea-upgrade-rituximab-igm-flare-prevention-comparison/> ;
  schema:dateModified "2026-11-16"^^xsd:date ;
  schema:citation <https://doi.org/10.1111/bjh.18036>, <https://doi.org/10.1002/jca.70141>, <https://doi.org/10.1182/blood-2018-06-846816>, <https://doi.org/10.1002/cncr.20658> ;
  onco:tag "protocol-upgrade", "upgrade:untested", "evidence:insufficient" ;
  onco:cancers <https://onco.cc/cancers/waldenstrom/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-rare-cancers/>, <https://onco.cc/bottlenecks/b-real-world-evidence/> .
